SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-16-030091
Filing Date
2016-12-12
Accepted
2016-12-09 18:08:52
Documents
9
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A rare-10qa_20160630.htm 10-Q/A 93150
2 EX-10.1 rare-ex101_6.htm EX-10.1 2545820
3 EX-10.2 rare-ex102_7.htm EX-10.2 3605444
4 EX-31.1 rare-ex311_26.htm EX-31.1 6620
5 EX-31.2 rare-ex312_27.htm EX-31.2 6776
6 GRAPHIC g2016120919561764015185.jpg GRAPHIC 3760
7 GRAPHIC g2016120919561763815184.jpg GRAPHIC 3792
8 GRAPHIC g2016120919563082617208.jpg GRAPHIC 3760
9 GRAPHIC g2016120919563082417207.jpg GRAPHIC 3792
  Complete submission text file 0001564590-16-030091.txt   6280262
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36276 | Film No.: 162044936
SIC: 2834 Pharmaceutical Preparations